Other OTC Pharmaceuticals - Europe

Europe

Highlights

In Europe, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$15.56bn in 2024.
It is projected that the market will experience an annual growth rate of 1.08% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue with US$7.17bn in 2024.
Taking into account the total population, the per person revenue in Europe is US$18.44 in 2024.
In Europe, the demand for Other OTC Pharmaceuticals is growing rapidly in countries like Germany due to an aging population and increasing health consciousness.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Europe is experiencing significant growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Europe are increasingly seeking self-care options for minor health issues, which has led to a rise in the demand for over-the-counter (OTC) pharmaceutical products. The convenience and accessibility of these products without the need for a prescription are highly appealing to consumers. Additionally, the growing awareness about the benefits of preventive healthcare and the increasing focus on personal well-being have further fueled the demand for OTC pharmaceuticals in Europe.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Europe is the increasing availability and popularity of online platforms for purchasing healthcare products. Online pharmacies and e-commerce platforms have made it easier for consumers to access a wide range of OTC pharmaceuticals from the comfort of their homes. This trend has been accelerated by the COVID-19 pandemic, which has led to a surge in online shopping across various sectors, including healthcare.Another trend in the market is the growing demand for natural and herbal OTC pharmaceutical products. Consumers in Europe are becoming more conscious about the ingredients used in healthcare products and are opting for natural alternatives whenever possible. This trend is driven by the perception that natural products are safer and have fewer side effects compared to synthetic pharmaceuticals.

Local special circumstances: Each country in Europe has its own unique set of regulations and healthcare systems, which can influence the development of the Other OTC Pharmaceuticals market. For example, countries with a more liberal approach to self-medication, such as the United Kingdom and Germany, have witnessed a higher growth rate in the market compared to countries with stricter regulations.Furthermore, the aging population in Europe is also contributing to the growth of the Other OTC Pharmaceuticals market. As the population ages, there is an increased prevalence of chronic conditions and a greater need for self-care options. This demographic shift is driving the demand for OTC pharmaceuticals, particularly in the areas of pain relief, digestive health, and vitamins/supplements.

Underlying macroeconomic factors: The overall economic stability and disposable income levels in Europe play a crucial role in the growth of the Other OTC Pharmaceuticals market. When consumers have higher disposable income, they are more likely to spend on healthcare products, including OTC pharmaceuticals. Additionally, the presence of a robust healthcare infrastructure and favorable reimbursement policies also contribute to the growth of the market.In conclusion, the Other OTC Pharmaceuticals market in Europe is witnessing significant growth due to customer preferences for self-care options, trends such as the rise of online platforms and the demand for natural products, local special circumstances including regulations and demographics, and underlying macroeconomic factors such as economic stability and healthcare infrastructure. These factors collectively drive the development and expansion of the market in Europe.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.